NCT01387425View on ClinicalTrials.gov

Efficacy And Safety Of Smoking Cessation With Varenicline Tartrate In Diabetic Smokers: (DIASMOKE)

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2015

Conditions
Smoking CessationDiabetes
Interventions
DRUG

varenicline

varenicline at a dose of 1 mg twice a day for 12 week

DRUG

placebo tablet is made of lactose

placebo at a dose of 1 mg twice for 12 week

Trial Locations (2)

95124

Centro per la Prevenzione e Cura del Tabagimso, Catania

Centro per la Prevenzione eCura del Tabagimso, Catania

All Listed Sponsors
lead

Universita degli Studi di Catania

OTHER

NCT01387425 - Efficacy And Safety Of Smoking Cessation With Varenicline Tartrate In Diabetic Smokers: (DIASMOKE) | Biotech Hunter | Biotech Hunter